Clinical Trials at Taylor Cancer Research Center
As of August 2026, 23 paid clinical trials are recruiting at Taylor Cancer Research Center in Maumee, Ohio. Active studies at this site cover conditions such as Non-Small Cell Lung Cancer, Pancreatic Cancer and Esophageal Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
23 clinical trials at Taylor Cancer Research Center
·Clear filters·Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
A Study of ASP3082 in Adults With Advanced Solid Tumors
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
GEMINI-NSCLC: NSCLC Biomarker Study
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
A Study to Assess the Safety, Tolerability, and Efficacy of NDI-219216 in Patients With Advanced Solid Tumors.
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Pan-tumor MRD Study
Common conditions studied in Maumee
- Non-Small Cell Lung Cancer (6 active studies)
- Pancreatic Cancer (5 active studies)
- Esophageal Cancer (4 active studies)
- PDAC - Pancreatic Ductal Adenocarcinoma (4 active studies)
- Type 2 Diabetes (4 active studies)
- Endometrial Cancer (3 active studies)
Leading research sponsors in Maumee
- AstraZeneca
- Revolution Medicines, Inc.
- Tempus AI
- Boehringer Ingelheim
- Novo Nordisk A/S
Frequently asked questions
How many paid clinical trials are currently recruiting in Maumee?
There are approximately 44 recruiting clinical trials in Maumee, Ohio listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Maumee pay participants?
Most recruiting trials in Maumee compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Maumee?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Maumee?
The most common conditions under active study in Maumee include Non-Small Cell Lung Cancer (6), Pancreatic Cancer (5), Esophageal Cancer (4), PDAC - Pancreatic Ductal Adenocarcinoma (4), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Maumee?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Maumee on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Maumee?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Maumee?
Recruiting research sites in Maumee include Taylor Cancer Research Center, Advanced Medical Research, Advanced Medical Research - Maumee, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Maumee right now?
The largest active categories in Maumee are Cancer & tumors (29), Diabetes & metabolic (6), Cardiovascular (5). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.